Global Osteoarthritis Pain Drugs Market Research Report 2023
Global Osteoarthritis Pain Drugs Market Research Report 2023
Abstract
Global Osteoarthritis Pain Drugs Market Overview:
Global Osteoarthritis Pain Drugs Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Osteoarthritis Pain Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Osteoarthritis Pain Drugs Market
The Osteoarthritis Pain Drugs Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Osteoarthritis Pain Drugs Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Osteoarthritis Pain Drugs Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Osteoarthritis Pain Drugs Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Osteoarthritis Pain Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Osteoarthritis Pain Drugs Market Segmentation
Global Osteoarthritis Pain Drugs Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Osteoarthritis Pain Drugs market has been segmented into:
Oral
Injection
External
By Application, Osteoarthritis Pain Drugs market has been segmented into:
Medical Care
Personal Care
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Osteoarthritis Pain Drugs market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Osteoarthritis Pain Drugs market.
Top Key Players Covered in Osteoarthritis Pain Drugs market are:
Pfizer
Bayer
SK Chemicals
GSK
Sanofi
Crystal Genomics
Johnson and Johnson
Sino Biopharmaceutical
Haohai Biological
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
Chugai Pharmaceutical
Mikasa Seiyaku
Taisho Pharmaceutical
Seikagaku Corporation
GlaxoSmithKline
Eli Lilly
Novartis
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Objective to buy this Report:
1. Osteoarthritis Pain Drugs analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Osteoarthritis Pain Drugs market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Content
Table of Contents
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Osteoarthritis Pain Drugs Market by Type
5.1 Osteoarthritis Pain Drugs Market Overview Snapshot and Growth Engine
5.2 Osteoarthritis Pain Drugs Market Overview
5.3 Oral
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Oral: Geographic Segmentation
5.4 Injection
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Injection: Geographic Segmentation
5.5 External
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 External: Geographic Segmentation
Chapter 6: Osteoarthritis Pain Drugs Market by Application
6.1 Osteoarthritis Pain Drugs Market Overview Snapshot and Growth Engine
6.2 Osteoarthritis Pain Drugs Market Overview
6.3 Medical Care
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Medical Care: Geographic Segmentation
6.4 Personal Care
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Personal Care: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Osteoarthritis Pain Drugs Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Osteoarthritis Pain Drugs Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Osteoarthritis Pain Drugs Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PFIZER
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 BAYER
7.4 SK CHEMICALS
7.5 GSK
7.6 SANOFI
7.7 CRYSTAL GENOMICS
7.8 JOHNSON AND JOHNSON
7.9 SINO BIOPHARMACEUTICAL
7.10 HAOHAI BIOLOGICAL
7.11 ZHEJIANG CHENGYI PHARMACEUTICAL
7.12 FREDA
7.13 BRIGHT FUTURE
7.14 JINGFENG PHARMACEUTICAL
7.15 CHUGAI PHARMACEUTICAL
7.16 MIKASA SEIYAKU
7.17 TAISHO PHARMACEUTICAL
7.18 SEIKAGAKU CORPORATION
7.19 GLAXOSMITHKLINE
7.20 ELI LILLY
7.21 NOVARTIS
7.22 HORIZON PHARMA
7.23 ABBOTT
7.24 MYLAN
7.25 DAIICHI SANKYO
7.26 TEVA
7.27 ALMATICA PHARMA
7.28 ASTELLAS PHARMA
7.29 TIDE PHARMACEUTICAL
7.30 IROKO PHARMACEUTICALS
7.31 HENGRUI PHARMACEUTICAL
Chapter 8: Global Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Oral
8.2.2 Injection
8.2.3 External
8.3 Historic and Forecasted Market Size By Application
8.3.1 Medical Care
8.3.2 Personal Care
Chapter 9: North America Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Oral
9.4.2 Injection
9.4.3 External
9.5 Historic and Forecasted Market Size By Application
9.5.1 Medical Care
9.5.2 Personal Care
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Europe Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Oral
10.4.2 Injection
10.4.3 External
10.5 Historic and Forecasted Market Size By Application
10.5.1 Medical Care
10.5.2 Personal Care
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
Chapter 11: Asia-Pacific Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Oral
11.4.2 Injection
11.4.3 External
11.5 Historic and Forecasted Market Size By Application
11.5.1 Medical Care
11.5.2 Personal Care
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
Chapter 12: Middle East & Africa Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Oral
12.4.2 Injection
12.4.3 External
12.5 Historic and Forecasted Market Size By Application
12.5.1 Medical Care
12.5.2 Personal Care
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
Chapter 13: South America Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Oral
13.4.2 Injection
13.4.3 External
13.5 Historic and Forecasted Market Size By Application
13.5.1 Medical Care
13.5.2 Personal Care
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
Chapter 14 Investment Analysis
Chapter 15 Analyst Viewpoint and Conclusion
Global Osteoarthritis Pain Drugs Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Osteoarthritis Pain Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Osteoarthritis Pain Drugs Market
The Osteoarthritis Pain Drugs Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Osteoarthritis Pain Drugs Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Osteoarthritis Pain Drugs Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Osteoarthritis Pain Drugs Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Osteoarthritis Pain Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Osteoarthritis Pain Drugs Market Segmentation
Global Osteoarthritis Pain Drugs Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Osteoarthritis Pain Drugs market has been segmented into:
Oral
Injection
External
By Application, Osteoarthritis Pain Drugs market has been segmented into:
Medical Care
Personal Care
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Osteoarthritis Pain Drugs market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Osteoarthritis Pain Drugs market.
Top Key Players Covered in Osteoarthritis Pain Drugs market are:
Pfizer
Bayer
SK Chemicals
GSK
Sanofi
Crystal Genomics
Johnson and Johnson
Sino Biopharmaceutical
Haohai Biological
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
Chugai Pharmaceutical
Mikasa Seiyaku
Taisho Pharmaceutical
Seikagaku Corporation
GlaxoSmithKline
Eli Lilly
Novartis
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Objective to buy this Report:
1. Osteoarthritis Pain Drugs analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Osteoarthritis Pain Drugs market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Osteoarthritis Pain Drugs Market by Type
5.1 Osteoarthritis Pain Drugs Market Overview Snapshot and Growth Engine
5.2 Osteoarthritis Pain Drugs Market Overview
5.3 Oral
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Oral: Geographic Segmentation
5.4 Injection
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Injection: Geographic Segmentation
5.5 External
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 External: Geographic Segmentation
Chapter 6: Osteoarthritis Pain Drugs Market by Application
6.1 Osteoarthritis Pain Drugs Market Overview Snapshot and Growth Engine
6.2 Osteoarthritis Pain Drugs Market Overview
6.3 Medical Care
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Medical Care: Geographic Segmentation
6.4 Personal Care
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Personal Care: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Osteoarthritis Pain Drugs Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Osteoarthritis Pain Drugs Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Osteoarthritis Pain Drugs Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PFIZER
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 BAYER
7.4 SK CHEMICALS
7.5 GSK
7.6 SANOFI
7.7 CRYSTAL GENOMICS
7.8 JOHNSON AND JOHNSON
7.9 SINO BIOPHARMACEUTICAL
7.10 HAOHAI BIOLOGICAL
7.11 ZHEJIANG CHENGYI PHARMACEUTICAL
7.12 FREDA
7.13 BRIGHT FUTURE
7.14 JINGFENG PHARMACEUTICAL
7.15 CHUGAI PHARMACEUTICAL
7.16 MIKASA SEIYAKU
7.17 TAISHO PHARMACEUTICAL
7.18 SEIKAGAKU CORPORATION
7.19 GLAXOSMITHKLINE
7.20 ELI LILLY
7.21 NOVARTIS
7.22 HORIZON PHARMA
7.23 ABBOTT
7.24 MYLAN
7.25 DAIICHI SANKYO
7.26 TEVA
7.27 ALMATICA PHARMA
7.28 ASTELLAS PHARMA
7.29 TIDE PHARMACEUTICAL
7.30 IROKO PHARMACEUTICALS
7.31 HENGRUI PHARMACEUTICAL
Chapter 8: Global Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Oral
8.2.2 Injection
8.2.3 External
8.3 Historic and Forecasted Market Size By Application
8.3.1 Medical Care
8.3.2 Personal Care
Chapter 9: North America Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Oral
9.4.2 Injection
9.4.3 External
9.5 Historic and Forecasted Market Size By Application
9.5.1 Medical Care
9.5.2 Personal Care
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Europe Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Oral
10.4.2 Injection
10.4.3 External
10.5 Historic and Forecasted Market Size By Application
10.5.1 Medical Care
10.5.2 Personal Care
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
Chapter 11: Asia-Pacific Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Oral
11.4.2 Injection
11.4.3 External
11.5 Historic and Forecasted Market Size By Application
11.5.1 Medical Care
11.5.2 Personal Care
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
Chapter 12: Middle East & Africa Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Oral
12.4.2 Injection
12.4.3 External
12.5 Historic and Forecasted Market Size By Application
12.5.1 Medical Care
12.5.2 Personal Care
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
Chapter 13: South America Osteoarthritis Pain Drugs Market Analysis, Insights and Forecast, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Oral
13.4.2 Injection
13.4.3 External
13.5 Historic and Forecasted Market Size By Application
13.5.1 Medical Care
13.5.2 Personal Care
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
Chapter 14 Investment Analysis
Chapter 15 Analyst Viewpoint and Conclusion
Related Report
